AAPL339.75+2.84 (+0.84%) ▲|ABBV264.59+7.68 (+2.99%) ▲|ABT107.57+3.08 (+2.95%) ▲|ACN164.99+10.93 (+7.09%) ▲|ADBE252.96+15.21 (+6.40%) ▲|AMAT475.24-41.66 (-8.06%) ▼|AMD460.25-34.70 (-7.01%) ▼|AMGN390.79+14.53 (+3.86%) ▲|AMT175.13+8.39 (+5.03%) ▲|AMZN231.48+0.09 (+0.04%) ▲|AVGO381.71-1.51 (-0.39%) ▼|AXP335.72+0.33 (+0.10%) ▲|BA222.58+11.08 (+5.24%) ▲|BAC62.36+0.23 (+0.36%) ▲|BKNG197.13+10.34 (+5.54%) ▲|BLK1,096.86+34.72 (+3.27%) ▲|BMY63.48+0.92 (+1.47%) ▲|BNY156.06-1.71 (-1.08%) ▼|BRK-B508.24+11.06 (+2.22%) ▲|C132.17-0.94 (-0.70%) ▼|CAT838.53-34.75 (-3.98%) ▼|CL93.86+1.88 (+2.04%) ▲|CMCSA24.19+1.39 (+6.07%) ▲|COF209.26+2.21 (+1.07%) ▲|COP113.26-2.32 (-2.01%) ▼|COST973.12+21.54 (+2.26%) ▲|CRM182.77+9.17 (+5.28%) ▲|CSCO116.50+1.93 (+1.68%) ▲|CVS108.64+1.57 (+1.47%) ▲|CVX186.78-3.22 (-1.69%) ▼|DE640.17+15.15 (+2.42%) ▲|DHR200.10+3.60 (+1.83%) ▲|DIS98.72+2.07 (+2.14%) ▲|DUK130.67+1.84 (+1.43%) ▲|EMR151.64+2.34 (+1.56%) ▲|FDX310.54-0.26 (-0.08%) ▼|GD392.61+3.47 (+0.89%) ▲|GE361.30-0.32 (-0.09%) ▼|GEV945.15-51.42 (-5.16%) ▼|GILD133.20+2.68 (+2.05%) ▲|GM90.53+3.49 (+4.01%) ▲|GOOG333.20+6.63 (+2.03%) ▲|GOOGL333.77+7.21 (+2.21%) ▲|GS1,042.47-5.76 (-0.55%) ▼|HD345.06+8.97 (+2.67%) ▲|HON248.75+3.00 (+1.22%) ▲|IBM225.94+9.66 (+4.47%) ▲|INTC86.69-4.98 (-5.43%) ▼|INTU315.30+11.39 (+3.75%) ▲|ISRG364.49+7.66 (+2.15%) ▲|JNJ269.01+3.06 (+1.15%) ▲|JPM355.84-0.36 (-0.10%) ▼|KO88.26+4.19 (+4.98%) ▲|LIN518.18+11.16 (+2.20%) ▲|LLY1,217.63+20.10 (+1.68%) ▲|LMT580.30+0.30 (+0.05%) ▲|LOW217.37+5.82 (+2.75%) ▲|LRCX268.04-23.58 (-8.08%) ▼|MA561.36+9.65 (+1.75%) ▲|MCD273.40+2.73 (+1.01%) ▲|MDLZ62.27+1.60 (+2.64%) ▲|MDT86.87+2.65 (+3.15%) ▲|META596.85+2.98 (+0.50%) ▲|MMM183.90+5.67 (+3.18%) ▲|MO74.89+2.00 (+2.74%) ▲|MRK131.95+1.19 (+0.91%) ▲|MS211.91-2.65 (-1.24%) ▼|MSFT398.28+9.18 (+2.36%) ▲|MU822.89-77.31 (-8.59%) ▼|NEE89.92+1.09 (+1.23%) ▲|NFLX73.21+2.81 (+3.98%) ▲|NKE42.98+0.84 (+1.99%) ▲|NOW110.53+4.97 (+4.70%) ▲|NVDA197.46+0.95 (+0.48%) ▲|ORCL120.67+0.77 (+0.64%) ▲|PEP142.06+2.27 (+1.62%) ▲|PFE25.17+0.50 (+2.01%) ▲|PG151.48+2.85 (+1.91%) ▲|PLTR123.89-7.64 (-5.81%) ▼|PM202.60+6.94 (+3.55%) ▲|QCOM165.44-4.60 (-2.71%) ▼|RTX217.24-1.18 (-0.54%) ▼|SBUX103.26-0.40 (-0.38%) ▼|SCHW105.92+1.74 (+1.67%) ▲|SO97.68+1.20 (+1.24%) ▲|SPG236.40+4.73 (+2.04%) ▲|T24.70+0.28 (+1.15%) ▲|TMO576.45+16.92 (+3.02%) ▲|TMUS184.08+6.87 (+3.88%) ▲|TSLA306.56-2.66 (-0.86%) ▼|TXN278.84-0.57 (-0.20%) ▼|UBER69.50+1.32 (+1.94%) ▲|UNH427.31+9.67 (+2.31%) ▲|UNP298.46-0.84 (-0.28%) ▼|UPS106.14-6.82 (-6.03%) ▼|USB63.97+0.48 (+0.76%) ▲|V368.87+6.34 (+1.75%) ▲|VZ48.23+0.91 (+1.91%) ▲|WFC86.87-0.41 (-0.46%) ▼|WMT113.94+2.20 (+1.96%) ▲|XOM152.34-2.44 (-1.57%) ▼|AAPL339.75+2.84 (+0.84%) ▲|ABBV264.59+7.68 (+2.99%) ▲|ABT107.57+3.08 (+2.95%) ▲|ACN164.99+10.93 (+7.09%) ▲|ADBE252.96+15.21 (+6.40%) ▲|AMAT475.24-41.66 (-8.06%) ▼|AMD460.25-34.70 (-7.01%) ▼|AMGN390.79+14.53 (+3.86%) ▲|AMT175.13+8.39 (+5.03%) ▲|AMZN231.48+0.09 (+0.04%) ▲|AVGO381.71-1.51 (-0.39%) ▼|AXP335.72+0.33 (+0.10%) ▲|BA222.58+11.08 (+5.24%) ▲|BAC62.36+0.23 (+0.36%) ▲|BKNG197.13+10.34 (+5.54%) ▲|BLK1,096.86+34.72 (+3.27%) ▲|BMY63.48+0.92 (+1.47%) ▲|BNY156.06-1.71 (-1.08%) ▼|BRK-B508.24+11.06 (+2.22%) ▲|C132.17-0.94 (-0.70%) ▼|CAT838.53-34.75 (-3.98%) ▼|CL93.86+1.88 (+2.04%) ▲|CMCSA24.19+1.39 (+6.07%) ▲|COF209.26+2.21 (+1.07%) ▲|COP113.26-2.32 (-2.01%) ▼|COST973.12+21.54 (+2.26%) ▲|CRM182.77+9.17 (+5.28%) ▲|CSCO116.50+1.93 (+1.68%) ▲|CVS108.64+1.57 (+1.47%) ▲|CVX186.78-3.22 (-1.69%) ▼|DE640.17+15.15 (+2.42%) ▲|DHR200.10+3.60 (+1.83%) ▲|DIS98.72+2.07 (+2.14%) ▲|DUK130.67+1.84 (+1.43%) ▲|EMR151.64+2.34 (+1.56%) ▲|FDX310.54-0.26 (-0.08%) ▼|GD392.61+3.47 (+0.89%) ▲|GE361.30-0.32 (-0.09%) ▼|GEV945.15-51.42 (-5.16%) ▼|GILD133.20+2.68 (+2.05%) ▲|GM90.53+3.49 (+4.01%) ▲|GOOG333.20+6.63 (+2.03%) ▲|GOOGL333.77+7.21 (+2.21%) ▲|GS1,042.47-5.76 (-0.55%) ▼|HD345.06+8.97 (+2.67%) ▲|HON248.75+3.00 (+1.22%) ▲|IBM225.94+9.66 (+4.47%) ▲|INTC86.69-4.98 (-5.43%) ▼|INTU315.30+11.39 (+3.75%) ▲|ISRG364.49+7.66 (+2.15%) ▲|JNJ269.01+3.06 (+1.15%) ▲|JPM355.84-0.36 (-0.10%) ▼|KO88.26+4.19 (+4.98%) ▲|LIN518.18+11.16 (+2.20%) ▲|LLY1,217.63+20.10 (+1.68%) ▲|LMT580.30+0.30 (+0.05%) ▲|LOW217.37+5.82 (+2.75%) ▲|LRCX268.04-23.58 (-8.08%) ▼|MA561.36+9.65 (+1.75%) ▲|MCD273.40+2.73 (+1.01%) ▲|MDLZ62.27+1.60 (+2.64%) ▲|MDT86.87+2.65 (+3.15%) ▲|META596.85+2.98 (+0.50%) ▲|MMM183.90+5.67 (+3.18%) ▲|MO74.89+2.00 (+2.74%) ▲|MRK131.95+1.19 (+0.91%) ▲|MS211.91-2.65 (-1.24%) ▼|MSFT398.28+9.18 (+2.36%) ▲|MU822.89-77.31 (-8.59%) ▼|NEE89.92+1.09 (+1.23%) ▲|NFLX73.21+2.81 (+3.98%) ▲|NKE42.98+0.84 (+1.99%) ▲|NOW110.53+4.97 (+4.70%) ▲|NVDA197.46+0.95 (+0.48%) ▲|ORCL120.67+0.77 (+0.64%) ▲|PEP142.06+2.27 (+1.62%) ▲|PFE25.17+0.50 (+2.01%) ▲|PG151.48+2.85 (+1.91%) ▲|PLTR123.89-7.64 (-5.81%) ▼|PM202.60+6.94 (+3.55%) ▲|QCOM165.44-4.60 (-2.71%) ▼|RTX217.24-1.18 (-0.54%) ▼|SBUX103.26-0.40 (-0.38%) ▼|SCHW105.92+1.74 (+1.67%) ▲|SO97.68+1.20 (+1.24%) ▲|SPG236.40+4.73 (+2.04%) ▲|T24.70+0.28 (+1.15%) ▲|TMO576.45+16.92 (+3.02%) ▲|TMUS184.08+6.87 (+3.88%) ▲|TSLA306.56-2.66 (-0.86%) ▼|TXN278.84-0.57 (-0.20%) ▼|UBER69.50+1.32 (+1.94%) ▲|UNH427.31+9.67 (+2.31%) ▲|UNP298.46-0.84 (-0.28%) ▼|UPS106.14-6.82 (-6.03%) ▼|USB63.97+0.48 (+0.76%) ▲|V368.87+6.34 (+1.75%) ▲|VZ48.23+0.91 (+1.91%) ▲|WFC86.87-0.41 (-0.46%) ▼|WMT113.94+2.20 (+1.96%) ▲|XOM152.34-2.44 (-1.57%) ▼|
26.3 C
New York
Tuesday, July 28, 2026

Tag: programs

Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD

Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory Evaluation

Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

PALMA DE MALLORCA, Spain, July 23, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid...

Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

PALMA DE MALLORCA, Spain, July 23, 2026 /CNW/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid...

Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering

Scribe Therapeutics announces pricing of upsized initial public offering

Save Remote Monitoring Coalition Launches to Oppose Flawed CMS Proposals in the 2027 Physician Fee Schedule

Providers and remote monitoring companies unite to defend a proven Medicare benefit and to demand real enforcement against bad actors in place of structural...

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 23, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery...

SIGGRAPH 2026 Unites Global Computer Graphics Community in Los Angeles With Landmark Keynotes, Inaugural Games Summit, and AI Innovation

Weeklong Conference Celebrates 53 Years of Advancing the State of the Art in Computer Graphics and Interactive TechniquesLOS ANGELES, July 23, 2026 /PRNewswire/ --...

Marquis Who’s Who Honors Weiqing Gu, PhD, for Expertise in AI and Healthcare

UNIONDALE, N.Y., July 22, 2026 /PRNewswire/ -- Marquis Who's Who honors Weiqing Gu, PhD, for expertise in AI and healthcare. Dr. Gu is the...

ALS Network Applauds House Passage of ACT for ALS Reauthorization Act

House approval marks a major milestone; ALS Network urges the Senate to act before September expirationLOS ANGELES, July 22, 2026 /PRNewswire/ -- The ALS...

Link Engineering Company (LINK) Receives VCA Authorization for Euro 7 Brake Emissions Type-Approval Testing

LIMBURG, Germany, July 22, 2026 /PRNewswire/ -- Link Engineering Company (LINK) announced that its laboratory in Limburg, Germany, has been authorized by the United...

ARMOUR Residential REIT, Inc. Announces Q2 Results and June 30, 2026 Financial Position

VERO BEACH, Florida, July 22, 2026 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR PRC) (“ARMOUR” or the “Company”) today announced the Company's unaudited Q2 results and June 30, 2026 financial position.

One Enduring Mission: Noridian Celebrates 60 Years of Medicare Stewardship

FARGO, N.D., July 22, 2026 (GLOBE NEWSWIRE) -- Noridian Healthcare Solutions, LLC (Noridian), a leader in developing solutions for federal, state and commercial health care programs, is celebrating a milestone year: 60 years of Medicare stewardship. Since 1966, Noridian has been responsible for supporting the Centers for Medicare & Medicaid Services (CMS) by delivering the administrative services needed to ensure Medicare beneficiaries receive essential care and that providers and medical equipment suppliers are properly reimbursed.

NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform

Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services.

PURECORE COMPLETES PHASE ONE EXPLORATION AT CRITICAL MINERALS PROJECT, BANKIER

VANCOUVER, BC, July 22, 2026 /CNW/ -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) ("Purecore" or the "Company") is pleased to announce geologists from HEG &...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrograms